Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Fibrocell Science Inc.
Fiscal year is January-December. All values USD millions. 2010 2011 2012 2013 5-year trend
Sales/Revenue - 936,369 812,235 153,000 200,000
Cost of Goods Sold (COGS) incl. D&A - 502,648 463,874 8.36M 8.05M
COGS excluding D&A - 494,563 306,118 7.53M 7.19M
Depreciation & Amortization Expense - 8,085 157,756 821,000 863,000
Depreciation - 8,085 157,756 269,000 300,000
Amortization of Intangibles - 0 - 552,000 563,000
Gross Income - 433,721 348,361 (8.2M) (7.85M)
2010 2011 2012 2013 5-year trend
SG&A Expense - 12M 20.38M 21.19M 22.65M
Research & Development - 5.49M 7.17M 9.02M 12.58M
Other SG&A - 6.52M 13.21M 12.17M 10.07M
Other Operating Expense - 0 0 0 0
Unusual Expense - 461,929 10.21M (4.28M) 1.05M
EBIT after Unusual Expense - (461,929) (10.21M) 4.28M (1.05M)
Non Operating Income/Expense - 244,479 0 0 0
Non-Operating Interest Income - 0 - 0 2,000
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense - 1.05M 1.06M 1.02M 0
Gross Interest Expense - 1.05M 1.06M 1.02M 0
Interest Capitalized - 0 0 0 0
Pretax Income - (12.83M) (31.31M) (26.13M) (31.55M)
Income Tax - 0 0 (2.5M) 0
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 - -
Income Tax - Deferred Domestic - 0 0 (2.5M) -
Income Tax - Deferred Foreign - 0 0 - -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income - (12.83M) (31.31M) (23.63M) (31.55M)
Minority Interest Expense - 51,898 18,209 24,000 0
Net Income - (12.88M) (31.33M) (23.65M) (31.55M)
Extraordinaries & Discontinued Operations - (48,805) (39,622) 456,000 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 467,000 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - (48,805) (39,622) (11,000) 0
Net Income After Extraordinaries - (12.93M) (31.37M) (23.19M) (31.55M)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (12.88M) (31.33M) (23.65M) (31.55M)
EPS (Basic) - (17.25) (14.25) (2.64) (1.06)
Basic Shares Outstanding - 750,310 2.19M 8.97M 29.83M
EPS (Diluted) - (17.25) (14.25) (2.64) (1.12)
Diluted Shares Outstanding - 750,310 2.19M 8.97M 30.2M
EBITDA - (11.56M) (19.88M) (28.57M) (29.64M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.